EP Patent

EP0686037A1 — Hormone replacement therapy

Assigned to Eastern Virginia Medical School · Expires 1995-12-13 · 30y expired

What this patent protects

A method of hormone replacement therapy involves the administration of estrogen together with an amount of antiprogestin which inhibits estrogen-induced endometrial proliferation in a woman.

USPTO Abstract

A method of hormone replacement therapy involves the administration of estrogen together with an amount of antiprogestin which inhibits estrogen-induced endometrial proliferation in a woman.

Drugs covered by this patent

Patent Metadata

Patent number
EP0686037A1
Jurisdiction
EP
Classification
—
Expires
1995-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Eastern Virginia Medical School
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.